1433357-83-5

Upstream product

• 1433362-85-6 5-(tert-butyl)-7-chloro-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine 
• 100243-39-8 3-hydroxypyrrolidine 
• 63777-70-8 2-chlorobenzylazide 
• 93444-91-8 5-amino-1-(2-chlorobenzyl)-1H-1,2,3-triazole-4-carboxamide 
• 1433362-83-4 5-tert-butyl-3-(2-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7(4H)-one 
• 611-17-6 1-bromomethyl-2-chlorobenzene 
• 611-19-8 1-chloro-2-(chloromethyl)benzene 
• 1433363-04-2 N-(1-(2-chlorobenzyl)-4-cyano-1H-1,2,3-triazol-5-yl)pivalamide 
• 1433363-02-0 1-(2-chlorobenzyl)-5-pivalamido-1H-1,2,3-triazole-4-carboxamide 

Relevant academic research and scientific papers

[1, 2, 3] TRIAZOLO [4, 5 -D] PYRIMIDINE DERIVATIVES AS AGONISTS OF THE CANNABINOID RECEPTOR 2

The invention relates to a compound of formula (I), wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament as agonists of the cannabinoid receptor 2.

NOVEL [1,2,3]TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES

The invention relates to a compound of formula (I) wherein A, R1 and R2 are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.